Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 May;88(2):350-5.
doi: 10.1111/j.1365-2249.1992.tb03086.x.

Effect of interferon-gamma priming on the activation of murine peritoneal macrophages to tumouricidal state by cisplatin, IL-1, and tumour necrosis factor (TNF): production of IL-1 and TNF

Affiliations

Effect of interferon-gamma priming on the activation of murine peritoneal macrophages to tumouricidal state by cisplatin, IL-1, and tumour necrosis factor (TNF): production of IL-1 and TNF

A Sodhi et al. Clin Exp Immunol. 1992 May.

Abstract

The effect of interferon-gamma (IFN-gamma) priming of murine peritoneal macrophages on the activation to tumouricidal state by cisplatin, lipopolysaccharide (LPS)-IL-1 and TNF was investigated. Cisplatin-, LPS-, IL-1- or TNF-treated IFN-gamma-primed macrophages showed significantly enhanced tumouricidal activity and binding to tumour cells, compared with unprimed treated or untreated macrophages. Macrophages treated with cisplatin, LPS, IL-1 and TNF produced released and membrane-associated IL-1 and TNF activity which was significantly enhanced after priming with IFN-gamma. These observations suggest the use of IFN-gamma along with these biological response modifiers in designing immunotherapeutic protocols for treatment of malignancy.

PubMed Disclaimer

References

    1. Immunol Lett. 1991 Mar;27(3):199-204 - PubMed
    1. J Immunol. 1981 May;126(5):1863-7 - PubMed
    1. Int J Immunopharmacol. 1990;12(8):893-8 - PubMed
    1. J Exp Med. 1986 Dec 1;164(6):2113-8 - PubMed
    1. Indian J Exp Biol. 1988 Sep;26(9):679-84 - PubMed

Publication types

MeSH terms